Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01966432 · ClinicalTrials.gov registry record · NA

Screening, Brief Intervention, and Referral to Treatment in Primary Care

A NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders, sponsored by Duke University.

Completed
Registry status
NA
Development phase
134
Enrollment target
1
Study location

NCT01966432: Completed NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders, sponsored by Duke University.

NCT01966432 is a NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders that has completed, run by Duke University. The registered enrollment target is 134 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01966432, a NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target
1
Study location

Study Summary

This add-on study of providing tobacco, alcohol and other drug screening, brief intervention and referral for treatment to a primary care high risk diabetic population leverages the existing research resources of a funded parent project "Duke University CMS Innovation Award Southeastern Diabetes initiative (PI: Robert M. Califf, MD)" to explore the feasibility of implementing Screening for substance use, Brief Intervention, and Referral to Treatment services in Primary Care (SBIRT-PC) and to examine the effects of substance use status on diabetes health care outcomes. This pilot study also examines the feasibility of the CTN's common data element algorithms of SBIRT for illicit and nonmedical drug use in the primary care setting.

Primary Outcome

Results of DAST-10 survey to determine use of illicit or nonmedical drugs.The Drug Abuse Screening Test (DAST-10) is a 10-item brief screening tool that assesses drug use, not including alcohol or tobacco use, in the past 12 months. Each question requires a yes or no response, and the tool can be completed in less than 8 minutes. DAST-10 scores on a 10-point scale. A score of 0 indicates no problems and 10 indicates a severe level of problems are associated with drug abuse.

Interventions

  • BEHAVIORAL Brief Intervention
  • BEHAVIORAL Referral to Treatment

Study Locations (1)

North Carolina

  • Durham County Department of Public Health - Durham

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2013-08
Est. Completion 2016-06
Phase NA
Duke University

1,725 total trials

What the finished NCT01966432 record still lists

NCT01966432 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Brief Intervention is the first listed.

NCT01966432 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01966432 about?

NCT01966432 is a clinical study titled "Screening, Brief Intervention, and Referral to Treatment in Primary Care". This add-on study of providing tobacco, alcohol and other drug screening, brief intervention and referral for treatment to a primary care high risk diabetic population leverages the existing research resources of a funded parent project "Duke University CMS Innovation Award Southeastern Diabetes ini...

What is the current status of trial NCT01966432?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2013-08. Estimated completion is 2016-06.

What conditions does trial NCT01966432 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Substance-Related Disorders.

What interventions are being tested in trial NCT01966432?

The interventions under investigation include: Brief Intervention (BEHAVIORAL), Referral to Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01966432?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01966432 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01966432's enrollment target sits among peer trials

134 182nd of 348 higher than 167 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02469662 · 134 participants · NA

    Clinical Outcomes Study of the Nexel Total Elbow

  • NCT03110822 · 134 participants · Phase 1

    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

  • NCT04678648 · 134 participants · Phase 1

    A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • NCT05264857 · 134 participants · NA

    Decision Aid and Thyroid Nodules Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01966432, the US trial registry maintained by the National Library of Medicine. NCT01966432 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.